Denmark· DK-28106674021
Bilastin "Nordic Prime"
A bilastin product containing bilastin, registered in Denmark by Nordic Prime ApS. The same ATC class is registered in 11 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Bilastin is registered in 11 of 19 countries.
Countries holding a registration under ATC R06AX29 (bilastin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Bilastin · ATC R06AX29
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of bilastin costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.14 in France to $0.45 in Switzerland — a ×3.3 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bilastin · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.45
- FR France$0.14
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Bilastin
- Manufacturer
- Nordic Prime ApS
- Country
- Denmark (DK)
- ATC code
- R06AX29
- ATC class
- Bilastin
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106674021
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R06AX29
Bilastin, as other registers publish it.
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/025ff573-5648-414a-8f7e-b9cffc57bcd1 GET /v1/drugs/025ff573-5648-414a-8f7e-b9cffc57bcd1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "tabletter",
"source": "dkma",
"strength": "20 mg",
"auth_role": "DKMA",
"dk_drugid": "28106674021",
"substance": "Bilastin",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "44812"
}See everything about bilastin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.